Voutilainen R, Miller W L
Department of Pediatrics, University of California, San Francisco 94143.
DNA. 1988 Jan-Feb;7(1):9-15. doi: 10.1089/dna.1988.7.9.
Insulin-like growth factor II (IGF-II) is regulated developmentally and hormonally in human fetal gonads and adrenals. The abundance of IGF-II mRNA is greatest in RNA from human fetal adrenals, followed by fetal liver, testis, placenta, and ovaries. Fetal testicular IGF-II mRNA decreases significantly with increasing gestational age, in parallel with our previous measurements of the mRNAs for the steroidogenic enzymes P450scc (cholesterol side-chain cleavage enzyme) and P450c17 (17 alpha-hydroxylase/17,20 lyase) (J. Clin. Endocrinol. Metab. 63, 1145, 1986). The abundances of P450scc and P450c17 mRNAs in cultured fetal testis cells rose 2.5-fold (p less than 0.01) and 9.2-fold (p less than 0.001), respectively, in response to 0.5 mM cAMP, but the abundance of IGF-II mRNA was not affected. This suggests that the IGF-II gene is regulated differently in fetal testes than it is in fetal adrenals, placenta, or adult granulosa cells, where we have previously shown that ACTH, cAMP, and gonadotropins, respectively, increase IGF-II mRNA accumulation (Proc. Natl. Acad. Sci. USA 84, 1590, 1987). Exogenously added IGF-I and IGF-II had no effect on mRNAs for P450c17 or P450c21 (21-hydroxylase), but decreased IGF-II mRNA in ACTH-stimulated fetal adrenal cells. Thus, the IGFs appear to exert short-loop feedback inhibition on accumulation of IGF-II mRNA.
胰岛素样生长因子II(IGF-II)在人类胎儿性腺和肾上腺中受到发育和激素的调控。IGF-II mRNA在人类胎儿肾上腺的RNA中丰度最高,其次是胎儿肝脏、睾丸、胎盘和卵巢。胎儿睾丸IGF-II mRNA随着胎龄增加而显著下降,这与我们之前对类固醇生成酶P450scc(胆固醇侧链裂解酶)和P450c17(17α-羟化酶/17,20裂解酶)mRNA的测量结果一致(《临床内分泌与代谢杂志》63卷,1145页,1986年)。在培养的胎儿睾丸细胞中,P450scc和P450c17 mRNA的丰度分别因0.5 mM cAMP而升高了2.5倍(p<0.01)和9.2倍(p<0.001),但IGF-II mRNA的丰度未受影响。这表明IGF-II基因在胎儿睾丸中的调控方式与胎儿肾上腺、胎盘或成年颗粒细胞不同,我们之前已表明,促肾上腺皮质激素、cAMP和促性腺激素分别会增加这些细胞中IGF-II mRNA的积累(《美国国家科学院院刊》84卷,1590页,1987年)。外源性添加的IGF-I和IGF-II对P450c17或P450c21(21-羟化酶)的mRNA没有影响,但会降低促肾上腺皮质激素刺激的胎儿肾上腺细胞中IGF-II mRNA的水平。因此,IGF似乎对IGF-II mRNA的积累发挥短环反馈抑制作用。